GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (XSAT:HAMLET B) » Definitions » Total Assets

Hamlet BioPharma AB publ (XSAT:HAMLET B) Total Assets : kr58.58 Mil (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Hamlet BioPharma AB publ Total Assets?

Hamlet BioPharma AB publ's Total Assets for the quarter that ended in Mar. 2025 was kr58.58 Mil.

During the past 12 months, Hamlet BioPharma AB publ's average Total Assets Growth Rate was -21.60% per year. During the past 3 years, the average Total Assets Growth Rate was 105.10% per year. During the past 5 years, the average Total Assets Growth Rate was 112.10% per year. During the past 10 years, the average Total Assets Growth Rate was 4.10% per year.

During the past 12 years, Hamlet BioPharma AB publ's highest 3-Year average Total Assets Growth Rate was 105.10%. The lowest was -84.30%. And the median was 32.20%.

Total Assets is connected with ROA %. Hamlet BioPharma AB publ's annualized ROA % for the quarter that ended in Mar. 2025 was -76.91%. Total Assets is also linked to Revenue through Asset Turnover. Hamlet BioPharma AB publ's Asset Turnover for the quarter that ended in Mar. 2025 was 0.00.


Hamlet BioPharma AB publ Total Assets Historical Data

The historical data trend for Hamlet BioPharma AB publ's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamlet BioPharma AB publ Total Assets Chart

Hamlet BioPharma AB publ Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.55 12.75 41.73 28.49 68.57

Hamlet BioPharma AB publ Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.73 68.57 62.30 71.50 58.58

Hamlet BioPharma AB publ Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Hamlet BioPharma AB publ's Total Assets for the fiscal year that ended in Jun. 2024 is calculated as

Total Assets=Total Equity (A: Jun. 2024 )+Total Liabilities (A: Jun. 2024 )
=64.458+4.108
=68.57

Hamlet BioPharma AB publ's Total Assets for the quarter that ended in Mar. 2025 is calculated as

Total Assets=Total Equity (Q: Mar. 2025 )+Total Liabilities (Q: Mar. 2025 )
=53.815+4.762
=58.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hamlet BioPharma AB publ  (XSAT:HAMLET B) Total Assets Explanation

Total Assets is connected with ROA %.

Hamlet BioPharma AB publ's annualized ROA % for the quarter that ended in Mar. 2025 is

ROA %=Net Income (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=-50.02/( (71.502+58.577)/ 2 )
=-50.02/65.0395
=-76.91 %

Note: The Net Income data used here is four times the quarterly (Mar. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Hamlet BioPharma AB publ's Asset Turnover for the quarter that ended in Mar. 2025 is

Asset Turnover
=Revenue (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=0/( (71.502+58.577)/ 2 )
=0/65.0395
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Hamlet BioPharma AB publ Total Assets Related Terms

Thank you for viewing the detailed overview of Hamlet BioPharma AB publ's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Hamlet BioPharma AB publ Business Description

Traded in Other Exchanges
Address
Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Hamlet BioPharma AB publ Headlines

No Headlines